PT  - JOURNAL ARTICLE
AU  - Patricia Combes
AU  - Maxime Bisseux
AU  - Antonin Bal
AU  - Pierre Marin
AU  - Christine Archimbaud
AU  - Amélie Brebion
AU  - Hélène Chabrolles
AU  - Christel Regagnon
AU  - Jérémy Lafolie
AU  - Gregory Destras
AU  - Bruno Simon
AU  - Laurence Josset
AU  - Cécile Henquell
AU  - Audrey Mirand
TI  - Evidence of co-infection during Delta and Omicron variants of concern co-circulation, weeks 49-2021 to 02-2022, France
AID  - 10.1101/2022.03.02.22271694
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.02.22271694
4099  - http://medrxiv.org/content/early/2022/03/03/2022.03.02.22271694.short
4100  - http://medrxiv.org/content/early/2022/03/03/2022.03.02.22271694.full
AB  - We report evidence of Delta/Omicron SARS-CoV-2 co-infections during the fifth wave of COVID-19 pandemics in France for 7 immunocompetent and epidemiologically unrelated patients. These co-infections were detected by PCR assays targeting SARS-CoV-2 S-gene mutations K417N and L452R and confirmed by whole genome sequencing which allowed the proportion estimation of each subpopulation. For 2 patients, the analyses of longitudinal samples collected 7 to 11 days apart showed that Delta or Omicron can outcompete the other variant during dual infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was based on national surveillance data. Informed consent was obtained from all patients. The study was approved by the review committee of the University Hospital of Clermont-Ferrand, France 2022/ CE06.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.